ZIVO Bioscience Balance Sheet Health

Financial Health criteria checks 0/6

ZIVO Bioscience has a total shareholder equity of $-2.1M and total debt of $355.0K, which brings its debt-to-equity ratio to -17%. Its total assets and total liabilities are $495.6K and $2.6M respectively.

Key information

-17.0%

Debt to equity ratio

US$355.01k

Debt

Interest coverage ration/a
CashUS$159.40k
Equity-US$2.08m
Total liabilitiesUS$2.58m
Total assetsUS$495.59k

Recent financial health updates

Recent updates

ZIVO Bioscience: Building An IP Portfolio For Algal Biomass Derived Ingredients

Nov 25

Financial Position Analysis

Short Term Liabilities: ZIVO has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: ZIVO has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: ZIVO has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: ZIVO's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ZIVO has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: ZIVO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 7.7% each year


Discover healthy companies